Arthropharm
Pharmaceutical Manufacturing • 
Sydney, New South Wales, Australia • 11-20 Employees
Company overview
| Headquarters | 111 BRONTE RD, BONDI JUNCTION, NSW 2022, AU |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 11-20 |
Key Contacts at Arthropharm
David Hill
Managing Director
Margaret Smith
Director Clinical Research
Arthropharm Email Formats
Arthropharm uses 1 email format. The most common is {first name} (e.g., john@arthropharm.com.au), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@arthropharm.com.au | 100% |
About Arthropharm
Arthropharm was founded in the 1980s and is based in Sydney, Australia, and operates in the research and development, manufacture, testing, and distribution of veterinary and human pharmaceuticals, with offices in the UK, Ireland, and Canada. The company pioneered the veterinary development of pentosan polysulfate (PPS) as a disease-modifying osteoarthritis drug under the brand Cartrophen®. In humans, Arthropharm has been the manufacturer and sponsor of Elmiron® (PPS) in Australia for >30 years, indicated as a safe and effective treatment for interstitial cystitis (IC).
Arthropharm revenue & valuation
| Annual revenue | $1,539,990 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $5,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Arthropharm has 8 employees across 5 departments.
Departments
Number of employees
Funding Data
Arthropharm has never raised funding before.
United Kingdom
Argentina
Poland
Germany
United States
SerbiaFrequently asked questions
4.8
40,000 users
